<div id="readability-page-1"><p>Abrams Bison Investments LLC boosted its position in shares of  Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 96.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor  owned 3,580,000 shares of the company's stock after purchasing an additional 1,760,000 shares during the period. Acadia Healthcare comprises  7.6% of Abrams Bison Investments LLC's holdings, making the stock its 6th largest position. Abrams Bison Investments LLC owned approximately 3.88% of Acadia Healthcare worth $81,230,000 as of its most recent filing with the Securities and Exchange Commission.</p><div><p><span></span><span>Get <strong>Acadia Healthcare</strong> alerts:</span></p></div><ul><li>Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?&#34;</li></ul><p>A number of other institutional investors also recently modified their holdings of the company. Allworth Financial LP grew its holdings in shares of  Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company's stock worth $31,000 after buying an additional 1,177 shares in the last quarter.  EverSource Wealth Advisors LLC boosted its position in  Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares during the last quarter.  Caitong International Asset Management Co. Ltd grew its stake in shares of  Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after acquiring an additional 1,234 shares in the last quarter.  CWM LLC raised its holdings in shares of  Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company's stock valued at $60,000 after purchasing an additional 1,349 shares during the last quarter.  Finally, Steward Partners Investment Advisory LLC lifted its position in shares of  Acadia Healthcare by 639.5% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company's stock worth $77,000 after purchasing an additional 2,916 shares in the last quarter. </p><h2>Acadia Healthcare Price Performance</h2><p>NASDAQ:ACHC opened at $14.28 on Friday. Acadia Healthcare Company, Inc. has a 12-month low of $12.63 and a 12-month high of $47.08. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of 12.21, a P/E/G ratio of 3.41 and a beta of 0.91. The stock's 50 day moving average price is $19.53 and its two-hundred day moving average price is $21.40. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. </p><p>Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts' consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The business had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. During the same period in the previous year, the firm earned $0.91 EPS. The firm's revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS.  On average, analysts anticipate that  Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year. </p><h2>Analysts Set New Price Targets</h2><p>ACHC has been the topic of several recent research reports. Guggenheim lowered their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a &#34;buy&#34; rating on the stock in a research note on Monday, November 10th. Raymond James Financial  set a $17.00 target price on Acadia Healthcare in a research report on Wednesday, December 3rd. Bank of America cut Acadia Healthcare from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and reduced their price target for the company from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Cantor Fitzgerald  set a $17.00 price target on Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Leerink Partnrs cut Acadia Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, December 3rd. Eight investment analysts have rated the stock with a Buy rating, six have issued  a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of &#34;Hold&#34; and an average target price of $23.17.</p><p><b>Read Our Latest Report on Acadia Healthcare</b></p><h2>About Acadia Healthcare</h2> (Free Report)<p>Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Acadia Healthcare</li><li>Roth IRA Calculator: Calculate Your Potential Returns</li><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li><li>Overbought Stocks Explained: Should You Trade Them?</li><li>The Best Holiday Present You Can Give Yourself? Costco Stock</li><li>3 Grocery Stocks That Are Proving They Are Still Essential </li><li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Acadia Healthcare Right Now?</h2><p>Before you consider Acadia Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.</p><p>While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ACHC

<p>Abrams Bison Investments LLC increased its stake in Acadia Healthcare by 96.7% in Q2, owning 3.88% of the company. Other investors also adjusted their holdings. Acadia's stock opened at $14.28, with a 12-month range of $12.63-$47.08. Analysts have mixed ratings, with a consensus "Hold" and an average target price of $23.17. Recent earnings exceeded expectations slightly, with revenue up 4.4% year-over-year. Acadia's FY 2025 EPS guidance is set at 2.350-2.450.</p>

Abrams Bison Investments LLC Boosts Stock Holdings in Acadia Healthcare Company, Inc. $ACHC